Evidence map›Paper›PMID 26770661›Full record

ReviewOxidative medicine and cellular longevity2016

The Role of Dopamine and Its Dysfunction as a Consequence of Oxidative Stress.

Hugo Juárez Olguín, David Calderón Guzmán, Ernestina Hernández García, Gerardo Barragán Mejía

Abstract readReview
In one paragraph

Review in Oxidative medicine and cellular longevity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 172 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
172citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

172 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Effect of a specificWorld journal of hepatology · 2022
    Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

112 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hugo Juárez OlguínLaboratorio de Farmacología, Instituto Nacional de Pediatría (INP), 04530 Ciudad de México, DF, Mexico; Departamento de Farmacología, Facultad de Medicina, Universidad Nacional Autónoma de Mexico, 04130 Ciudad de México, DF, Mexico.
David Calderón GuzmánLaboratorio de Neuroquimica, INP, 04530 Ciudad de México, DF, Mexico.
Ernestina Hernández GarcíaLaboratorio de Farmacología, Instituto Nacional de Pediatría (INP), 04530 Ciudad de México, DF, Mexico.
Gerardo Barragán MejíaLaboratorio de Neuroquimica, INP, 04530 Ciudad de México, DF, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dopamine is a neurotransmitter that is produced in the substantia nigra, ventral tegmental area, and hypothalamus of the brain. Dysfunction of the dopamine system has been implicated in different nervous system diseases. The level of dopamine transmission increases in response to any type of reward and by a large number of strongly additive drugs. The role of dopamine dysfunction as a consequence of oxidative stress is involved in health and disease. Introduce new potential targets for the development of therapeutic interventions based on antioxidant compounds. The present review focuses on the therapeutic potential of antioxidant compounds as a coadjuvant treatment to conventional neurological disorders is discussed.

Indexed as

Oxidative StressAnimalsAntidepressive AgentsDopamineEndocrine SystemHumansNeuroprotective AgentsReceptors, DopamineAntidepressive AgentsDopamineNeuroprotective AgentsReceptors, Dopamine

Identifiers

PMID26770661
PMCPMC4684895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.